Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase 8 (JNK1) is a serine/threonine-protein kinase belonging to the c-Jun N-terminal kinase (JNK) subfamily of the mitogen-activated protein kinase (MAPK) superfamily. It is activated by dual-specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 in response to environmental stress, pro-inflammatory cytokines, and DNA damage. Upon activation, JNK1 phosphorylates various transcription factors, most notably c-Jun, which regulates the activity of the AP-1 transcription factor complex to control cell proliferation, differentiation, and apoptosis. Dysregulation of JNK1 signaling is heavily implicated in the pathogenesis of chronic inflammatory diseases, metabolic disorders like insulin resistance and type 2 diabetes, fibrosis, and various cancers. Consequently, JNK1 has emerged as a significant therapeutic target, with several small-molecule inhibitors, such as BMS-986360 and CC-930, developed to block its kinase activity. However, because JNK1 is ubiquitously expressed and plays critical roles in normal physiological processes, achieving high selectivity and avoiding systemic toxicity remain major challenges in drug development.
ATP-competitive inhibition of serine/threonine-protein kinase activity, covalent inhibition of the conserved cysteine residue in the active site, or peptide-mediated inhibition of substrate binding.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase 8 (JNK1) (JNK1).